Bortezomib, 250 mg

Bortezumib is a recognized compound in chemical applications, identified as a peptide aldehyde. Its molecular formula is C51H69N13O12, with a molecular weight of 1016.2 g/mol. This compound belongs to the class of proteasome inhibitors, specifically targeting the 26S proteasome. It is supplied in a 250 mg form, making it suitable for various applications within the field of ligand research. Additionally, Bortezumib exhibits potent anticancer activity, particularly against multiple myeloma, due to its ability to selectively inhibit the chymotrypsin-like activity of the 20S proteasome subunit.

• CAS Number: 179324-69-7